在SARS-CoV-2亚型BA.2.86,JN.1,KP.2和KP.3中复制和免疫逃避的比较分析
Yanping Hu1, Jing Zou1, Michael D Nguyen2
1Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
mBio
|April 29, 2025
概括
在SARS-CoV-2变异中的特定突变,如JN.1,KP.2和KP.3,增强病毒复制和免疫逃避. 这些变化推动了新的严重急性呼吸综合征冠状病毒2 (SARS-CoV-2) 菌株的进化和主导地位.
科学领域:
- 病毒学 病毒学
- 分子生物学分子生物学
- 流行病学 流行病学
背景情况:
- 严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) BA.2.86亚系已经演变为后代菌株JN.1,KP.2和KP.3,其特点是尖蛋白中出现反复突变.
- 驱动这些SARS-CoV-2变种的流行病学继承和主导的精确机制仍然不完全理解.
研究的目的:
- 研究免疫逃避和复制适应能力在SARS-CoV-2 BA.2.86后代进化的作用.
- 阐明尖端受体结合域 (RBD) 中的特定突变如何影响病毒特征并驱动变体的出现.
主要方法:
- 评估了SARS-CoV-2菌株 (BA.2.86,JN.1,KP.2,KP.3) 在人类呼吸道表皮细胞中的复制适应性.
- 评估了这些菌株对来自XBB.1.5和JN.1感染的人类血清的中和敏感性.
- 分析了特定突变 (R346T,L455S,F456L,Q493E) 对尖切割和病毒性质的影响.
主要成果:
- 突变L455S和Q493E影响尖裂变,影响病毒性质.
- 由于L455S,JN.1表现出增加的中和阻力,导致BA.2.86向JN.1过渡.
- KP.2表现出由组合突变 (R346T,L455S,F456L) 引起的增强复制和免疫逃避,导致JN.1转向KP.2.
- 与KP.2相比,KP.3表现出优越的复制性,Q493E可能会增强健康状况,并推动KP.2到KP.3的过渡.
结论:
- 在SARS-CoV-2 BA.2.86后代中经常出现的尖端突变微调病毒复制和免疫逃避,促进它们的出现和主导地位.
- 了解这些进化动态对于开发针对不断演变的SARS-CoV-2变种的更新对策至关重要.
- 特定的RBD突变可以影响尖生物学,包括裂变,为SARS-CoV-2病原体提供新的见解.
相关概念视频
01:05Single Nucleotide Polymorphisms-SNPs
14.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.9K
00:57Viral Recombination
23.3K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.3K
00:36Viral Mutations
32.2K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.2K
02:28Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
02:26Comparing Copy Number Variations and SNPs
17.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K